Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
21 results
D1.202 - Small-Spotted Catshark Parvalbumin Sensitization in Fish-Allergic Patients
D1.203 - Pine Nut Allergy in a Pediatric Patient with Multiple Sensitizations to Tree Nuts and Storage Proteins
D1.204 - Pea-ling Back the Layers: A Systematic Review of Pea Allergies
D1.205 - Characterization of a cohort of fish allergic portuguese patients
D1.206 - A 50-year history of IgE-mediated hypersensitivity reactions to Saccharomyces cerevisiae presenting with respiratory symptoms
D1.207 - “Do nut know what: What is the current role of the prick test and serum IgE in the diagnosis of walnut allergy?
D1.208 - Clinical relevance of food allergen families
D1.209 - Pollen and Food Non-Specific Lipid Transfer Proteins: Clinical Presentations and Sensitization Profiles in a Mediterranean Population
D1.210 - Effects of Omalizumab on Human Basophils in Children with Cow’s Milk Protein Allergy
D1.212 - IgE mediated allergic reaction to rice
D1.213 - Exercise-Induced Anaphylaxis in a 18-Year-Old Woman with Egg Allergy and Potential Bird-Egg Syndrome
D1.214 - Food Allergy:Even in doubt, Challenge Test
D1.149 - Murine IgG1 increased y subcutaneous immunotherapy suppressed development of allergic asthma
D1.150 - Study design for the saFety assessment of an Accelerated up-dosing scheme using one Strength of a native house dust mite allergen extract for subcutaneous immunoTherapy in children with allergic asthma in China (FAST II study)
D1.152 - Incidence of patients who needed to change their allergy immunotherapy product specific to mites or pollens in Spanish allergy unitsIncidence of switching specific allergic immunotherapy products in Spanish allergy units
D1.153 - Protocol for a randomized, 5-arm study to evaluate the combination of omalizumab and allergen immunotherapy in patients with asthma due to house dust mites
D1.154 - Safety of ultra-rush immunotherapy starting protocol with the molecular extract Diater Alt a 1 mol mix
D1.155 - Alterations in B cell memory induced by house dust mite allergen immunotherapy
D1.156 - Early Immunologic Parameters Predicting Response to Sublingual Immunotherapy in Allergic Rhinitis Patients
D1.157 - Type II Cytokine-Mediated Regulation of Alarmin Receptors in B Cells: Implications for Eosinophilic Esophagitis
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download